Parnell Pharmace Stock Price, News & Analysis

Parnell Pharmaceuticals Holdings Ltd (PARNF) is a leading global veterinary pharmaceutical business with over fifty years of experience marketing products in 15 countries. The company has a strong focus on R&D, clinical science, and regulatory processes. Following recent FDA accreditation of its sterile manufacturing facility in Sydney, Australia, Parnell has the capability to swiftly bring innovative solutions to the market. Parnell offers unique digital technology solutions that complement its innovative products, providing veterinarians and animal owners with superior animal health solutions. The company's market-leading portfolio includes products for companion, performance, and production animals, such as cattle breeding programs, osteoarthritis solutions for dogs and horses, and a pipeline of products spanning anesthesia, anti-microbials, orthopedics, and laminitis.